Cargando…

Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833552/
https://www.ncbi.nlm.nih.gov/pubmed/36630339
http://dx.doi.org/10.1371/journal.pone.0279162
_version_ 1784868267487133696
collection PubMed
description
format Online
Article
Text
id pubmed-9833552
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-98335522023-01-12 Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis PLoS One Expression of Concern Public Library of Science 2023-01-11 /pmc/articles/PMC9833552/ /pubmed/36630339 http://dx.doi.org/10.1371/journal.pone.0279162 Text en © 2023 The PLOS ONE Editors https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Expression of Concern
Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title_full Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title_fullStr Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title_full_unstemmed Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title_short Expression of Concern: Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
title_sort expression of concern: impact of the superoxide dismutase 2 val16ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis
topic Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833552/
https://www.ncbi.nlm.nih.gov/pubmed/36630339
http://dx.doi.org/10.1371/journal.pone.0279162
work_keys_str_mv AT expressionofconcernimpactofthesuperoxidedismutase2val16alapolymorphismontherelationshipbetweenvalproicacidexposureandelevationofgglutamyltransferaseinpatientswithepilepsyapopulationpharmacokineticpharmacodynamicanalysis